Patents by Inventor David James Phillips

David James Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC METHOD
    Publication number: 20150359846
    Abstract: The present invention relates generally to a method of modulating an inflammatory response in a mammal and to agents useful for same. More particularly, the present invention relates to a method of modulating an inflammatory response in a mammal by modulating the functional activity of activin and thereby modulating the pro-inflammatory mediator cascade. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by an aberrant, unwanted or otherwise inappropriate inflammatory response including, inter alia, sepsis and inflammation of the airway. The present invention is further directed to methods for identifying and/or designing agents capable of modulating activin mediated regulation of the inflammatory response.
    Type: Application
    Filed: November 13, 2014
    Publication date: December 17, 2015
    Applicant: Paranta Biosciences Limited
    Inventors: DAVID MORRITZ DE KRETSER, DAVID JAMES PHILLIPS, KRISTIAN LEE JONES, ROBYN O'HEHIR, SHANE PATELLA
  • Method of modulating inflammatory response by downregulation of activin
    Patent number: 8920806
    Abstract: The present invention relates generally to a method of modulating an inflammatory response in a mammal and to agents useful for same. More particularly, the present invention relates to a method of modulating an inflammatory response in a mammal by modulating the functional activity of activin and thereby modulating the pro-inflammatory mediator cascade. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterized by an aberrant, unwanted or otherwise inappropriate inflammatory response including, inter alia, sepsis and inflammation of the airway. The present invention is further directed to methods for identifying and/or designing agents capable of modulating activin mediated regulation of the inflammatory response.
    Type: Grant
    Filed: October 6, 2004
    Date of Patent: December 30, 2014
    Assignee: Paranta Biosciences Limited
    Inventors: David Morritz De Kretser, David James Phillips, Kristian Lee Jones, Robyn O'Hehir, Shane Patella